×




Synthes Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Synthes case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Synthes case study is a Harvard Business School (HBR) case study written by John T. Gourville. The Synthes (referred as “Synthes Implants” from here on) case study provides evaluation & decision scenario in field of Sales & Marketing. It also touches upon business topics such as - Value proposition, Product development.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Synthes Case Study


Synthes is the recognized leader in the U.S. orthopedic implant market, with a 50% market share in the metallic plates, rods, and screws used to fix severe bone fractures. Synthes' marketplace strength lies in the strength of its sales force and in the quality and reliability of its products. A major drawback to all metallic implants, however, is that they often need to be removed after the bones have healed. To address this problem, several major competitors have recently introduced polymer-based "bioresorbable" implants. In theory, these new implants remain rigid while the fracture heals, then gradually dissolve, eliminating their need for removal. In reality, however, some of these new implants have proven problematic--causing infection, incomplete healing, or the need for a second surgery. This leaves Synthes debating whether to enter the bioresorbable market and risk a high-profile product failure or to remain an observer and allow others to test the market and eventually validate (or invalidate) the concept.


Case Authors : John T. Gourville

Topic : Sales & Marketing

Related Areas : Product development




Calculating Net Present Value (NPV) at 6% for Synthes Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10018276) -10018276 - -
Year 1 3453590 -6564686 3453590 0.9434 3258104
Year 2 3979579 -2585107 7433169 0.89 3541811
Year 3 3970127 1385020 11403296 0.8396 3333395
Year 4 3236608 4621628 14639904 0.7921 2563697
TOTAL 14639904 12697007




The Net Present Value at 6% discount rate is 2678731

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Internal Rate of Return
2. Payback Period
3. Profitability Index
4. Net Present Value

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Synthes Implants shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.
2. Timing of the expected cash flows – stockholders of Synthes Implants have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.






Formula and Steps to Calculate Net Present Value (NPV) of Synthes

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Sales & Marketing Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Synthes Implants often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Synthes Implants needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10018276) -10018276 - -
Year 1 3453590 -6564686 3453590 0.8696 3003122
Year 2 3979579 -2585107 7433169 0.7561 3009133
Year 3 3970127 1385020 11403296 0.6575 2610423
Year 4 3236608 4621628 14639904 0.5718 1850541
TOTAL 10473219


The Net NPV after 4 years is 454943

(10473219 - 10018276 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10018276) -10018276 - -
Year 1 3453590 -6564686 3453590 0.8333 2877992
Year 2 3979579 -2585107 7433169 0.6944 2763597
Year 3 3970127 1385020 11403296 0.5787 2297527
Year 4 3236608 4621628 14639904 0.4823 1560864
TOTAL 9499980


The Net NPV after 4 years is -518296

At 20% discount rate the NPV is negative (9499980 - 10018276 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Synthes Implants to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Synthes Implants has a NPV value higher than Zero then finance managers at Synthes Implants can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Synthes Implants, then the stock price of the Synthes Implants should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Synthes Implants should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What can impact the cash flow of the project.

What will be a multi year spillover effect of various taxation regulations.

Understanding of risks involved in the project.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Synthes

References & Further Readings

John T. Gourville (2018), "Synthes Harvard Business Review Case Study. Published by HBR Publications.


Mainland Headwear SWOT Analysis / TOWS Matrix

Consumer Cyclical , Apparel/Accessories


Gentherm SWOT Analysis / TOWS Matrix

Consumer Cyclical , Auto & Truck Parts


Swelect Energy Systems Ltd SWOT Analysis / TOWS Matrix

Technology , Electronic Instr. & Controls


Hopewell Holdings SWOT Analysis / TOWS Matrix

Capital Goods , Construction Services


Sarine Technologies Ltd SWOT Analysis / TOWS Matrix

Capital Goods , Misc. Capital Goods


Il Dong Pharm SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Asia Seed SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Crops


Iterum Therapeutics SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Sanden Corp SWOT Analysis / TOWS Matrix

Capital Goods , Misc. Capital Goods


Hubei Yingtong Telecom SWOT Analysis / TOWS Matrix

Consumer Cyclical , Audio & Video Equipment